HAO Fundamental Analysis - HAOXI HEALTH TECHNOLOGY LTD

Name: HAOXI HEALTH TECHNOLOGY LTD (HAO) Stock
Brand: HAOXI HEALTH TECHNOLOGY LTD
Rating: 1.5 (3 reviews)

Fundamental Rating

Overall HAO gets a fundamental rating of 5 out of 10. We evaluated HAO against 95 industry peers in the Media industry. While HAO has a great health rating, its profitability is only average at the moment. While showing a medium growth rate, HAO is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year HAO was profitable.

In the past year HAO has reported a negative cash flow from operations.

1.2 Ratios

HAO has a better Return On Assets (13.23%) than 95.79% of its industry peers.

With an excellent Return On Equity value of 18.20%, HAO belongs to the best of the industry, outperforming 89.47% of the companies in the same industry.

HAO has a better Return On Invested Capital (15.84%) than 96.84% of its industry peers.

		Industry Rank	Sector Rank
ROA	13.23%
ROE	18.2%
ROIC	15.84%

ROA(3y)25.06%

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin of HAO (2.85%) is better than 64.21% of its industry peers.

In the last couple of years the Profit Margin of HAO has grown nicely.

The Operating Margin of HAO (3.52%) is comparable to the rest of the industry.

In the last couple of years the Operating Margin of HAO has grown nicely.

Looking at the Gross Margin, with a value of 5.49%, HAO is doing worse than 83.16% of the companies in the same industry.

HAO's Gross Margin has improved in the last couple of years.

		Industry Rank	Sector Rank
OM	3.52%
PM (TTM)	2.85%
GM	5.49%

OM growth 3Y11.17%

OM growth 5YN/A

PM growth 3Y4.01%

PM growth 5YN/A

GM growth 3Y6.32%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), HAO is creating value.

Compared to 1 year ago, HAO has more shares outstanding

HAO has a better debt/assets ratio than last year.

2.2 Solvency

HAO has an Altman-Z score of 6.50. This indicates that HAO is financially healthy and has little risk of bankruptcy at the moment.

With an excellent Altman-Z score value of 6.50, HAO belongs to the best of the industry, outperforming 91.58% of the companies in the same industry.

A Debt/Equity ratio of 0.10 indicates that HAO is not too dependend on debt financing.

Looking at the Debt to Equity ratio, with a value of 0.10, HAO is in the better half of the industry, outperforming 73.68% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.1
Debt/FCF	N/A
Altman-Z	6.5

ROIC/WACC2.51

WACC6.3%

2.3 Liquidity

A Current Ratio of 3.98 indicates that HAO has no problem at all paying its short term obligations.

HAO has a Current ratio of 3.98. This is amongst the best in the industry. HAO outperforms 94.74% of its industry peers.

A Quick Ratio of 3.98 indicates that HAO has no problem at all paying its short term obligations.

Looking at the Quick ratio, with a value of 3.98, HAO belongs to the top of the industry, outperforming 94.74% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	3.98
Quick Ratio	3.98

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

HAO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 68.32%, which is quite impressive.

Measured over the past years, HAO shows a very strong growth in Earnings Per Share. The EPS has been growing by 61.60% on average per year.

HAO shows a strong growth in Revenue. In the last year, the Revenue has grown by 92.62%.

The Revenue has been growing by 55.73% on average over the past years. This is a very strong growth!

EPS 1Y (TTM)68.32%

EPS 3Y61.6%

EPS 5YN/A

EPS Q2Q%38.82%

Revenue 1Y (TTM)92.62%

Revenue growth 3Y55.73%

Revenue growth 5YN/A

Sales Q2Q%71.88%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

HAO is valuated correctly with a Price/Earnings ratio of 12.57.

Compared to the rest of the industry, the Price/Earnings ratio of HAO indicates a somewhat cheap valuation: HAO is cheaper than 72.63% of the companies listed in the same industry.

Compared to an average S&P500 Price/Earnings ratio of 25.89, HAO is valued rather cheaply.

		Industry Rank	Sector Rank
PE	12.57
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	-1.7

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

HAO does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

HAOXI HEALTH TECHNOLOGY LTD

NASDAQ:HAO (11/14/2025, 8:00:01 PM)

0.88

-0.03 (-2.93%)

Chartmill FA Rating

GICS SectorCommunication Services

GICS IndustryGroupMedia & Entertainment

GICS IndustryMedia

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners0.98%

Inst Owner Change0%

Ins Owners21.79%

Ins Owner ChangeN/A

Market Cap2.48M

Revenue(TTM)72.02M

Net Income(TTM)2.05M

Analysts0

Price TargetN/A

Short Float %4.29%

Short Ratio0.12

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	12.57
Fwd PE	N/A
P/S	0.03
P/FCF	N/A
P/OCF	N/A
P/B	0.22
P/tB	0.22
EV/EBITDA	-1.7

EPS(TTM)0.07

EY7.95%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-0.28

FCFYN/A

OCF(TTM)-0.27

OCFYN/A

SpS25.54

BVpS4

TBVpS4

PEG (NY)N/A

PEG (5Y)N/A

Graham Number2.51

Profitability

		Industry Rank	Sector Rank
ROA	13.23%
ROE	18.2%
ROCE	21.78%
ROIC	15.84%
ROICexc	35.58%
ROICexgc	35.58%
OM	3.52%
PM (TTM)	2.85%
GM	5.49%
FCFM	N/A

ROA(3y)25.06%

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)19.92%

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3Y11.17%

OM growth 5YN/A

PM growth 3Y4.01%

PM growth 5YN/A

GM growth 3Y6.32%

GM growth 5YN/A

F-Score3

Asset Turnover4.64

Health

		Industry Rank	Sector Rank
Debt/Equity	0.1
Debt/FCF	N/A
Debt/EBITDA	0.45
Cap/Depr	522.64%
Cap/Sales	0.08%
Interest Coverage	67.98
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	3.98
Quick Ratio	3.98
Altman-Z	6.5

F-Score3

WACC6.3%

ROIC/WACC2.51

Cap/Depr(3y)486.59%

Cap/Depr(5y)N/A

Cap/Sales(3y)0.11%

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)68.32%

EPS 3Y61.6%

EPS 5YN/A

EPS Q2Q%38.82%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)92.62%

Revenue growth 3Y55.73%

Revenue growth 5YN/A

Sales Q2Q%71.88%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y50.42%

EBIT growth 3Y73.12%

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y12.49%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y14.28%

OCF growth 3YN/A

OCF growth 5YN/A

HAOXI HEALTH TECHNOLOGY LTD / HAO FAQ

What is the ChartMill fundamental rating of HAOXI HEALTH TECHNOLOGY LTD (HAO) stock?

ChartMill assigns a fundamental rating of 5 / 10 to HAO.

What is the valuation status for HAO stock?

ChartMill assigns a valuation rating of 2 / 10 to HAOXI HEALTH TECHNOLOGY LTD (HAO). This can be considered as Overvalued.

What is the profitability of HAO stock?

HAOXI HEALTH TECHNOLOGY LTD (HAO) has a profitability rating of 5 / 10.

What are the PE and PB ratios of HAOXI HEALTH TECHNOLOGY LTD (HAO) stock?

The Price/Earnings (PE) ratio for HAOXI HEALTH TECHNOLOGY LTD (HAO) is 12.57 and the Price/Book (PB) ratio is 0.22.

HAOXI HEALTH TECHNOLOGY LTD (HAO) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

HAOXI HEALTH TECHNOLOGY LTD / HAO FAQ

What is the ChartMill fundamental rating of HAOXI HEALTH TECHNOLOGY LTD (HAO) stock?

What is the valuation status for HAO stock?

What is the profitability of HAO stock?

What are the PE and PB ratios of HAOXI HEALTH TECHNOLOGY LTD (HAO) stock?